StromaPath builds AI-powered pipelines that transform molecular complexity into clinical-grade insight — from target identification to validated docking results. StromaPath 以 AI 驅動流程，將分子層次的複雜度轉化為可落地臨床的洞見——從標靶辨識到經驗證的對接結果。
Each product addresses a distinct bottleneck in the drug discovery and precision medicine pipeline — deployable independently or as an integrated stack. 每項產品對應藥物發現與精準醫療流程中的關鍵瓶頸——可獨立部署，亦可整合為一體化堆疊。
A 27-stage human-in-the-loop QC pipeline for molecular docking. Processes drug candidates through triple-engine docking (AutoDock Vina), pose clustering, interaction analysis, and confidence-tier assignment. 20 drugs complete, 18 Tier A validated. 以人機協作為核心的 27 階分子對接品質管控流程。候選藥物經三引擎對接（AutoDock Vina）、構象分群、交互作用分析與信賴分級。已完成 20 種藥物、18 件達 A 級驗證。
Precomputed docking dashboard for drug repurposing screening. Integrates ADMET profiling, MolMIM analog generation, and 24-case showboard with target receptor selection across validated datasets. 預計算對接儀表板，支援藥物再利用篩選。整合 ADMET、MolMIM 類似物生成，以及 24 案例展示板與標靶受體選擇。
Inverse pharmacovigilance signal detection using EBGM Bayesian estimation on FDA FAERS data. Identifies drugs with anomalously low adverse event reporting — a proprietary repurposing signal layer. 以 FDA FAERS 資料結合 EBGM 貝氏估計的逆向藥物安全信號偵測，辨識不良反應通報異常偏低的藥物——專屬再利用信號層。
DTI fiber tractography viewer with TDA-based topological analysis. Includes ISLES stroke lesion integration, TSM clinical interpretation framework, and 3D organ visualization suite. Built in Three.js on DGX compute. DTI 神經束路檢視與拓樸資料分析（TDA）。整合 ISLES 中風病灶、TSM 臨床解讀框架與 3D 器官視覺化。Three.js + DGX 運算環境。
Manifold-based framework (M-CIM) for cancer gene prioritization using multi-omics data — mRNA, miRNA, and clinical metadata. Geometric prognostic singularity analysis for BRCA and beyond. Published preprint 2026. 以流形為基礎的 M-CIM 框架，整合 mRNA、miRNA 與臨床後設資料做多體學癌症基因排序。含 BRCA 等幾何預後奇異點分析。2026 預印本已發表。
Three.js viewer for renal organ Gaussian splats with optional tumor mesh highlight. Serve KidneyProject over HTTP and place PLY assets under web/models. 以 Three.js 檢視腎臟器官高斯噴濺與選用之腫瘤網格高亮。請以 HTTP 提供 KidneyProject，並將 PLY 模型置於 web/models。
We work with pharma partners, CROs, and research institutions on tailored pipeline deployments. Schedule a technical discussion. 我們與藥廠、CRO 與研究單位合作，可依需求部署流程——歡迎預約技術討論。
Talk to us →與我們聯絡 →MolGate's five-module architecture processes every drug candidate through systematic quality gates — with human review embedded at critical decision points. MolGate 五模組架構讓每位候選藥物經過系統性品質門檻；在關鍵決策點嵌入人工審閱。
Every platform is grounded in published or preprint research. Full technical documentation available under NDA for qualified partners. 各平台皆以已發表或預印本研究為基礎；符合資格的合作夥伴可在簽署 NDA 後取得完整技術文件。
Available for licensing through Fu Jen Catholic University tech transfer. Three tiers for pharma partners, CROs, and strategic investors. 可循輔仁大學技轉機制取得授權；提供藥廠／CRO／策略投資人三種層級方案。
Non-commercial research access to the MolGate QC pipeline, reporting framework, and published datasets.MolGate QC 流程、報告框架與已發表資料集之非營利用途存取。
Full platform deployment for pharma, biotech, and CRO partners. Dedicated compute and SLA included.為藥廠、生物技術公司與 CRO 提供的完整部署；含專用算力與 SLA。
AI narrows millions to hundreds.
StromaPath gives those hundreds their credibility.
AI 將候選從百萬級收斂到數百級
StromaPath 為這數百項補上可信度
Whether you're exploring licensing, investment, or a research collaboration — we respond to every serious inquiry within 48 hours. 若您正在評估授權、投資或研究合作，我們會在 48 小時內回覆每一份嚴謹的詢問。
Full technical data room — including all 20 drug run QC reports, platform architecture documentation, and IP portfolio — available under executed NDA for qualified investors and pharma partners.完整技術資料室——含全部 20 份藥物 QC 報告、平台架構文件與 IP 組合——符合資格的投資人與藥廠夥伴可於簽署 NDA 後取得。